218 related articles for article (PubMed ID: 26048187)
1. A Retrospective Evaluation of Inpatient Transfer from High-Dose Methadone to Buprenorphine Substitution Therapy.
Oretti R
J Subst Abuse Treat; 2015 Oct; 57():102-5. PubMed ID: 26048187
[TBL] [Abstract][Full Text] [Related]
2. Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines.
Lintzeris N; Monds LA; Rivas C; Leung S; Dunlop A; Newcombe D; Walters C; Galea S; White N; Montebello M; Demirkol A; Swanson N; Ali R
J Addict Med; 2018; 12(3):234-240. PubMed ID: 29509558
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
Curcio F; Franco T; Topa M; Baldassarre C;
Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
[TBL] [Abstract][Full Text] [Related]
4. Methadone to buprenorphine/naloxone induction without withdrawal utilizing transdermal fentanyl bridge in an inpatient setting-Azar method.
Azar P; Nikoo M; Miles I
Am J Addict; 2018 Dec; 27(8):601-604. PubMed ID: 30387894
[TBL] [Abstract][Full Text] [Related]
5. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
McKeganey N; Russell C; Cockayne L
J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715
[TBL] [Abstract][Full Text] [Related]
6. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls.
Rapeli P; Fabritius C; Alho H; Salaspuro M; Wahlbeck K; Kalska H
BMC Clin Pharmacol; 2007 Jun; 7():5. PubMed ID: 17565668
[TBL] [Abstract][Full Text] [Related]
7. Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.
Rosado J; Walsh SL; Bigelow GE; Strain EC
Drug Alcohol Depend; 2007 Oct; 90(2-3):261-9. PubMed ID: 17517480
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive memantine for opioid use disorder treatment: A systematic review.
Elias AM; Pepin MJ; Brown JN
J Subst Abuse Treat; 2019 Dec; 107():38-43. PubMed ID: 31757263
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
[TBL] [Abstract][Full Text] [Related]
10. Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
Gomes T; Campbell TJ; Kitchen SA; Garg R; Bozinoff N; Men S; Tadrous M; Munro C; Antoniou T; Werb D; Wyman J
JAMA; 2022 Mar; 327(9):846-855. PubMed ID: 35230394
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone.
Strain EC; Preston KL; Liebson IA; Bigelow GE
J Pharmacol Exp Ther; 1995 Feb; 272(2):628-38. PubMed ID: 7853176
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder.
Becker WC; Ganoczy D; Fiellin DA; Bohnert AS
J Subst Abuse Treat; 2015 Jan; 48(1):128-31. PubMed ID: 25312475
[TBL] [Abstract][Full Text] [Related]
13. Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series.
Nielsen S; Bruno R; Degenhardt L; Demirkol A; Lintzeris N
Drug Alcohol Rev; 2017 May; 36(3):311-316. PubMed ID: 27273511
[TBL] [Abstract][Full Text] [Related]
14. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol.
Terasaki D; Smith C; Calcaterra SL
Pharmacotherapy; 2019 Oct; 39(10):1023-1029. PubMed ID: 31348544
[TBL] [Abstract][Full Text] [Related]
15. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Post-Cesarean Section Opioid Analgesic Requirements in Women With Opioid Use Disorder Treated With Methadone or Buprenorphine.
Vilkins AL; Bagley SM; Hahn KA; Rojas-Miguez F; Wachman EM; Saia K; Alford DP
J Addict Med; 2017; 11(5):397-401. PubMed ID: 28727661
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.
Maremmani I; Gerra G
Am J Addict; 2010; 19(6):557-68. PubMed ID: 20958853
[TBL] [Abstract][Full Text] [Related]
18. Memory function in opioid-dependent patients treated with methadone or buprenorphine along with benzodiazepine: longitudinal change in comparison to healthy individuals.
Rapeli P; Fabritius C; Kalska H; Alho H
Subst Abuse Treat Prev Policy; 2009 Apr; 4():6. PubMed ID: 19374740
[TBL] [Abstract][Full Text] [Related]
19. Transfer from high dose methadone to buprenorphine/naloxone.
Wallace M
Aust Nurs J; 2011 Jul; 19(1):42-3. PubMed ID: 21853690
[No Abstract] [Full Text] [Related]
20. The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.
Socias ME; Ahamad K; Le Foll B; Lim R; Bruneau J; Fischer B; Wild TC; Wood E; Jutras-Aswad D
Contemp Clin Trials; 2018 Jun; 69():21-27. PubMed ID: 29627621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
